Jennifer Jarrett - Net Worth and Insider Trading

Jennifer Jarrett Net Worth

The estimated net worth of Jennifer Jarrett is at least $3 Million dollars as of 2024-06-08. Jennifer Jarrett is the COO of Arcus Biosciences Inc and owns about 215,253 shares of Arcus Biosciences Inc (RCUS) stock worth over $3 Million. Details can be seen in Jennifer Jarrett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer Jarrett has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).

Transaction Summary of Jennifer Jarrett

To

Jennifer Jarrett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer Jarrett owns 9 companies in total, including Arcus Biosciences Inc (RCUS) , Arena Pharmaceuticals Inc (ARNA) , and Syndax Pharmaceuticals Inc (SNDX) among others .

Click here to see the complete history of Jennifer Jarrett’s form 4 insider trades.

Insider Ownership Summary of Jennifer Jarrett

Ticker Comapny Transaction Date Type of Owner
RCUS Arcus Biosciences Inc 2024-03-27 See Remarks
ARNA Arena Pharmaceuticals Inc 2020-06-12 director
SNDX Syndax Pharmaceuticals Inc 2018-09-25 director
LIMIT LIMIT 2020-01-15 director
LIMIT LIMIT 2016-09-28 Chief Financial Officer
LIMIT LIMIT 2021-08-11 other: Former Director
LIMIT LIMIT 2022-08-15 director
LIMIT LIMIT 2021-08-11 other: Former Director
LIMIT LIMIT 2023-03-20 director

Jennifer Jarrett Latest Holdings Summary

Jennifer Jarrett currently owns a total of 1 stock. Jennifer Jarrett owns 215,253 shares of Arcus Biosciences Inc (RCUS) as of March 27, 2024, with a value of $3 Million.

Latest Holdings of Jennifer Jarrett

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RCUS Arcus Biosciences Inc 2024-03-27 215,253 15.50 3,336,422

Holding Weightings of Jennifer Jarrett


Jennifer Jarrett Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer Jarrett has made a total of 19 transactions in Arcus Biosciences Inc (RCUS) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Arcus Biosciences Inc is the sale of 11,551 shares on March 27, 2024, which brought Jennifer Jarrett around $202,720.

Insider Trading History of Jennifer Jarrett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer Jarrett Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jennifer Jarrett Ownership Network

Ownership Network List of Jennifer Jarrett

No Data

Ownership Network Relation of Jennifer Jarrett

Insider Network Chart

Jennifer Jarrett Owned Company Details

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Jennifer Jarrett is the See Remarks of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include director & 10 percent owner & President Juan C. Jaen , 10 percent owner Gilead Sciences Inc , and Chief Financial Officer Goeltz Ii Robert C. .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, Jennifer Jarrett made 11 insider transaction in Arcus Biosciences Inc (RCUS) with a net sale of 223,626. Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 38,443 shares made by Juan C. Jaen , a net sale of 8,506 shares made by Goeltz Ii Robert C. , and a net purchase of 16,248,095 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 25,000 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 25,000 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcus Biosciences Inc Insider Transactions

No Available Data

Jennifer Jarrett Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer Jarrett. You might contact Jennifer Jarrett via mailing address: C/o Medivation, Inc., 525 Market St., 36th Floor, San Francisco Ca 94105.

Discussions on Jennifer Jarrett

No discussions yet.